Steroids and the management of macular edema

Shani Golan*, Anat Loewenstein

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Macular edema (ME) is a condition which is usually secondary to an underlying disease process. It is most commonly seen following venous occlusive disease, diabetic retinopathy and posterior segment inflammatory disease. The treatment of ME varies, depending upon the underlying etiology, and has led to varying degrees of success. Traditionally, the main treatment options have included topical and systemic steroids, due to their known antiangiogenic, antiedematous, antiinflammatory and antiproliferative effects. This comprehensive review outlines the current use of steroids and highlights the ever-growing indications for steroids in ME secondary to various ocular conditions as well as the recent breakthrough results of the efficacy of this treatment.

Original languageEnglish
Pages (from-to)31-40
Number of pages10
Issue numberSUPPL. 1
StatePublished - Aug 2010


  • Macular edema
  • Steroids


Dive into the research topics of 'Steroids and the management of macular edema'. Together they form a unique fingerprint.

Cite this